Factors associated with long-term use of hypnotics among patients with chronic insomnia

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Takaesu, Yoshikazu ^a   Komada, Yoko ^a,b   Asaoka, Shoichi ^a   Kagimura, Tatsuo ^c   Inoue, Yuichi ^a,b  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b NEUROPSYCHIATRIC RESEARCH INSTITUTE   (Japan)

^c FOUNDATION FOR BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BENZODIAZEPINE RECEPTOR STIMULATING AGENT; HYPNOTIC SEDATIVE AGENT;

ADL DISABILITY; ADULT; ARTICLE; CHRONIC DISEASE; CHRONIC DRUG ADMINISTRATION; DAYTIME SOMNOLENCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FOLLOW UP; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PITTSBURGH SLEEP QUALITY INDEX; QUESTIONNAIRE; SCORING SYSTEM; SELF EVALUATION; SLEEP PATTERN; SLEEP QUALITY; TREATMENT DURATION; TREATMENT OUTCOME; ZUNG SELF RATING DEPRESSION SCALE; AGED; AREA UNDER THE CURVE; COGNITIVE THERAPY; DEMOGRAPHY; DEPRESSION; METABOLISM; MIDDLE AGED; ODDS RATIO; PATHOLOGY; PHYSIOLOGY; RECEIVER OPERATING CHARACTERISTIC; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; STATISTICAL MODEL;

ADULT; AGED; AREA UNDER CURVE; BENZODIAZEPINES; COGNITIVE THERAPY; DEMOGRAPHY; DEPRESSION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; ROC CURVE; SLEEP; SLEEP INITIATION AND MAINTENANCE DISORDERS; TREATMENT OUTCOME;

EID: 84915746975     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113753     Document Type: Article

References (35)

1. Ancoli-Israel S, Roth T (1999) Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. Sleep 22 Suppl 2: S347-353.
2. Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M (2000) Prevalence of insomnia in a survey of 12, 778 adults in France. J Sleep Res 9: 35-42.
3. Ohayon MM (2002) Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 6: 97-111.
4. Kim K, Uchiyama M, Okawa M, Liu X, Ogihara R (2000) An epidemiological study of insomnia among the Japanese general population. Sleep 23: 41-47.
5. Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA (1999) Quality of life in people with insomnia. Sleep 22 Suppl 2: S379-385.
6. Spiegel K, Leproult R, Van Cauter E (1999) Impact of sleep debt on metabolic and endocrine function. Lancet 354: 1435-1439.
7. Suka M, Yoshida K, Sugimori H (2003) Persistent insomnia is a predictor of hypertension in Japanese male workers. J Occup Health 45: 344-350.
8. Roth T, Ancoli-Israel S (1999) Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. II. Sleep 22 Suppl 2: S354-358.
9. Johnson EO, Roth T, Breslau N (2006) The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 40: 700-708.
10. Roane BM, Taylor DJ (2008) Adolescent insomnia as a risk factor for early adult depression and substance abuse. Sleep 31: 1351-1356.
11. Soldatos CR, Dikeos DG, Whitehead A (1999) Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. Int Clin Psychopharmacol 14: 287-303.
12. Roehrs T, Pedrosi B, Rosenthal L, Roth T (1996) Hypnotic self administration and dose escalation. Psychopharmacology (Berl) 127: 150-154.
13. Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 4: 487-504.
14. Lader MH (1999) Limitations on the use of benzodiazepines in anxiety and insomnia: are they justified? Eur Neuropsychopharmacol 9 Suppl 6: S399-405.
15. Ohayon MM, Caulet M (1996) Psychotropic medication and insomnia complaints in two epidemiological studies. Can J Psychiatry 41: 457-464.
16. (2005) NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements 22: 1-30.
17. Doi Y, Minowa M, Uchiyama M, Okawa M, Kim K, et al. (2000) Psychometric assessment of subjective sleep quality using the Japanese version of the Pittsburgh Sleep Quality Index (PSQI-J) in psychiatric disordered and control subjects. Psychiatry Res 97: 165-172.
18. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 28: 193-213.
19. Zung WW (1965) A Self-Rating Depression Scale. Arch Gen Psychiatry 12: 63-70.
20. Rickels K, Case WG, Downing RW, Winokur A (1983) Long-term diazepam therapy and clinical outcome. JAMA 250: 767-771.
21. Lader M (2014) Benzodiazepine harm: how can it be reduced? Br J Clin Pharmacol 77: 295-301.
22. Stepanski EJ, Wyatt JK (2003) Use of sleep hygiene in the treatment of insomnia. Sleep Med Rev 7: 215-225.
23. Shapiro DE (1999) The interpretation of diagnostic tests. Stat Methods Med Res 8: 113-134.
24. Swets JA (1988) Measuring the accuracy of diagnostic systems. Science 240: 1285-1293.
25. Morin CM, LeBlanc M, Daley M, Gregoire JP, Merette C (2006) Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med 7: 123-130.
26. Morgan K, Thompson J, Dixon S, Tomeny M, Mathers N (2003) Predicting longer-term outcomes following psychological treatment for hypnotic-dependent chronic insomnia. J Psychosom Res 54: 21-29.
27. Wade AG, Ford I, Crawford G, McMahon AD, Nir T, et al. (2007) Efficacy of prolonged release melatonin in insomnia patients aged 55-80 years: quality of sleep and next-day alertness outcomes. Curr Med Res Opin 23: 2597-2605.
28. Baillargeon L, Landreville P, Verreault R, Beauchemin JP, Gregoire JP, et al. (2003) Discontinuation of benzodiazepines among older insomniac adults treated with cognitive-behavioural therapy combined with gradual tapering: a randomized trial. CMAJ 169: 1015-1020.
29. Riemann D, Voderholzer U (2003) Primary insomnia: a risk factor to develop depression? J Affect Disord 76: 255-259.
30. Dundar Y, Dodd S, Strobl J, Boland A, Dickson R, et al. (2004) Comparative efficacy of newer hypnotic drugs for the short-term management of insomnia: a systematic review and meta-analysis. Hum Psychopharmacol 19: 305-322.
31. Allain H, Delahaye C, Le Coz F, Blin P, Decombe R, et al. (1991) Postmarketing surveillance of zopiclone in insomnia: analysis of 20, 513 cases. Sleep 14: 408-413.
32. Buscemi N, Vandermeer B, Friesen C, Bialy L, Tubman M, et al. (2007) The efficacy and safety of drug treatments for chronic insomnia in adults: a meta-analysis of RCTs. J Gen Intern Med 22: 1335-1350.
33. Rosenberg RP (2006) Sleep maintenance insomnia: strengths and weaknesses of current pharmacologic therapies. Ann Clin Psychiatry 18: 49-56.
34. Soeffing JP, Lichstein KL, Nau SD, McCrae CS, Wilson NM, et al. (2008) Psychological treatment of insomnia in hypnotic-dependant older adults. Sleep Med 9: 165-171.
35. Morin CM, Bastien C, Guay B, Radouco-Thomas M, Leblanc J, et al. (2004) Randomized clinical trial of supervised tapering and cognitive behavior therapy to facilitate benzodiazepine discontinuation in older adults with chronic insomnia. Am J Psychiatry 161: 332-342.